Skip to content

Drug interactions

Duloxetine + Somatrogon

Severity: Minor

Duloxetine and Somatrogon: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Growth hormone therapy may increase hepatic CYP450 activity and thereby reduce exposure to duloxetine, a CYP1A2 substrate. Evidence is limited and any effect is likely small, but reduced therapeutic response is possible.

What this interaction means in plain words

Duloxetine and Somatrogon have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Duloxetine belongs to Central Nervous System; Somatrogon belongs to Endocrine.

Evidence level: Low

Why it happens

Growth hormone may induce CYP1A2-mediated metabolism, increasing duloxetine clearance.

What to do

Monitor clinical response to duloxetine when somatrogon is started or stopped. Titrate the duloxetine dose only if efficacy declines.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duloxetine and Somatrogon, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Duloxetine with Somatrogon?

MediHelp rates the interaction as minor. Duloxetine and Somatrogon have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Growth hormone therapy may increase hepatic CYP450 activity and thereby reduce exposure to duloxetine, a CYP1A2 substrate. Evidence is limited and any effect is likely small, but reduced therapeutic response is possible.

How serious is the interaction between Duloxetine and Somatrogon?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response to duloxetine when somatrogon is started or stopped. Titrate the duloxetine dose only if efficacy declines.

What other medicines interact with Duloxetine?

MediHelp also lists interactions of Duloxetine with, for example, Isocarboxazid, Linezolid, Methylene blue. The full list is on the Duloxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in